1. Home
  2. MQ vs HROW Comparison

MQ vs HROW Comparison

Compare MQ & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marqeta Inc.

MQ

Marqeta Inc.

HOLD

Current Price

$3.98

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$34.10

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MQ
HROW
Founded
2010
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MQ
HROW
Price
$3.98
$34.10
Analyst Decision
Hold
Strong Buy
Analyst Count
10
8
Target Price
$5.36
$71.14
AVG Volume (30 Days)
4.6M
924.6K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$624,884,000.00
N/A
Revenue This Year
$17.47
$44.68
Revenue Next Year
$16.47
$40.71
P/E Ratio
N/A
N/A
Revenue Growth
23.25
N/A
52 Week Low
$3.48
$20.85
52 Week High
$7.04
$54.98

Technical Indicators

Market Signals
Indicator
MQ
HROW
Relative Strength Index (RSI) 43.71 27.80
Support Level $3.83 $30.55
Resistance Level $4.94 $40.64
Average True Range (ATR) 0.18 2.54
MACD 0.02 -1.45
Stochastic Oscillator 50.86 2.31

Price Performance

Historical Comparison
MQ
HROW

About MQ Marqeta Inc.

Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: